Times Not to Forget Radiotherapy When Treating Patients With Lymphoma

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Radiation therapy remains an important component of lymphoma treatment. It has evolved with improvements in technology and a better understanding of how to successfully integrate it into lymphoma treatment. There are specific clinical presentations where omission of radiation therapy could adversely affect patient outcome and should not be overlooked. Radiation therapy may serve an important role as primary treatment, as a component of combined modality therapy, as adjuvant therapy to maximize local control, and as an important component of salvage therapy for relapsed or primary refractory lymphoma and in the successful palliation of lymphoma. This review identifies those clinical presentations where the use of radiation therapy should not be overlooked or should at least be considered.

Original languageEnglish (US)
Pages (from-to)167-172
Number of pages6
JournalJournal of oncology practice
Volume15
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Lymphoma
Radiotherapy
Salvage Therapy
Combined Modality Therapy
Therapeutics
Technology

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Times Not to Forget Radiotherapy When Treating Patients With Lymphoma. / Enke, Charles Arthur.

In: Journal of oncology practice, Vol. 15, No. 4, 01.04.2019, p. 167-172.

Research output: Contribution to journalArticle

@article{318c732676ef49bfb8a8a68caacd18c9,
title = "Times Not to Forget Radiotherapy When Treating Patients With Lymphoma",
abstract = "Radiation therapy remains an important component of lymphoma treatment. It has evolved with improvements in technology and a better understanding of how to successfully integrate it into lymphoma treatment. There are specific clinical presentations where omission of radiation therapy could adversely affect patient outcome and should not be overlooked. Radiation therapy may serve an important role as primary treatment, as a component of combined modality therapy, as adjuvant therapy to maximize local control, and as an important component of salvage therapy for relapsed or primary refractory lymphoma and in the successful palliation of lymphoma. This review identifies those clinical presentations where the use of radiation therapy should not be overlooked or should at least be considered.",
author = "Enke, {Charles Arthur}",
year = "2019",
month = "4",
day = "1",
doi = "10.1200/JOP.18.00519",
language = "English (US)",
volume = "15",
pages = "167--172",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "4",

}

TY - JOUR

T1 - Times Not to Forget Radiotherapy When Treating Patients With Lymphoma

AU - Enke, Charles Arthur

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Radiation therapy remains an important component of lymphoma treatment. It has evolved with improvements in technology and a better understanding of how to successfully integrate it into lymphoma treatment. There are specific clinical presentations where omission of radiation therapy could adversely affect patient outcome and should not be overlooked. Radiation therapy may serve an important role as primary treatment, as a component of combined modality therapy, as adjuvant therapy to maximize local control, and as an important component of salvage therapy for relapsed or primary refractory lymphoma and in the successful palliation of lymphoma. This review identifies those clinical presentations where the use of radiation therapy should not be overlooked or should at least be considered.

AB - Radiation therapy remains an important component of lymphoma treatment. It has evolved with improvements in technology and a better understanding of how to successfully integrate it into lymphoma treatment. There are specific clinical presentations where omission of radiation therapy could adversely affect patient outcome and should not be overlooked. Radiation therapy may serve an important role as primary treatment, as a component of combined modality therapy, as adjuvant therapy to maximize local control, and as an important component of salvage therapy for relapsed or primary refractory lymphoma and in the successful palliation of lymphoma. This review identifies those clinical presentations where the use of radiation therapy should not be overlooked or should at least be considered.

UR - http://www.scopus.com/inward/record.url?scp=85064721580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064721580&partnerID=8YFLogxK

U2 - 10.1200/JOP.18.00519

DO - 10.1200/JOP.18.00519

M3 - Article

VL - 15

SP - 167

EP - 172

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 4

ER -